Blogs

Latest Blogs

[wd_asp id=2]

Beyond Weight Loss: How Incretins Are Redefining Obesity Drug Development

Incretin therapies are changing obesity treatment. Discover why future obesity drug development will be defined by outcomes beyond weight loss.…

Allogeneic CAR-T Cell Therapies: A major step forward

In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…

A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology

Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…

The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers

Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…

The STING Effect: How Biomarkers Expose Harmful Immune Responses

In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…

Falling drug approval rates: What should we be doing differently?

Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…

Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer

We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…